Neurons use chemical 'chords' to shape signaling

Researchers have discovered that neurons can use two different neurotransmitters that target the same receptor on a receiving neuron to shape the transmission of a nerve impulse. Although the researchers’ experiments identified the “co-release” of the two neurotransmitters only in specific types of neurons in the brain’s auditory center, their finding may apply more broadly in the brain, they said. Thus, the finding may represent a new way in which the brain precisely modulates the nerve impulses that travel from neuron to neuron in its circuitry.

Tao Lu and colleagues Maria Rubio and Laurence Trussell reported their findings in the February 28, 2008, issue of the journal Neuron, published by Cell Press.

To propagate a nerve impulse within neural circuitry, one neuron launches a burst of chemical signal called a neurotransmitter at a receiving neuron, where the neurotransmitter attaches to a specific receptor—like a key fitting a lock. That neurotransmitter-specific receptor is activated to trigger a nerve impulse in the receiving neuron.

Such nerve impulses, however, rather than being the electrical equivalent of a shotgun blast, are precisely modulated signals, like the finely shaped notes of an orchestra.

In studies over the past several decades, researchers had found evidence for co-release of different neurotransmitters by the same neuron. But they had assumed that in such cotransmission, each neurotransmitter targeted its own receptor on the receiving neuron.

However, Lu and colleagues performed biochemical and electrophysiological experiments on rat neurons and established that two neurotransmitters—called GABA and glycine—both target the glycine receptor in specific types of neurons. The neurons they studied reside in the part of the rat auditory system that processes sound location. Thus, shaping the timing of the nerve impulse is important for such processing.

Glycine acts as an inhibitory neurotransmitter in such neurons, and Lu and colleagues found that GABA acts on the glycine receptor to accelerate glycine-produced inhibition.

Lu and colleagues wrote that, although their studies only establish the role of GABA/glycine cotransmission in the specialized auditory neurons, other studies had found evidence for cotransmission in other areas of the brain. Such findings hint that the two neurotransmitters may work in concert elsewhere “at a single receptor to enhance the temporal resolution of inhibition.”

“Of course, a hallmark of a great scientific study is the ability to approach an established problem from a fresh perspective,” wrote Joshua Singer in a preview of the article in the same issue of Neuron. “And certainly the present work by Lu, Rubio, and Trussell characterizes this.” Singer, who is at Northwestern University, asked, “Who would have thought that GABA [is a natural trigger for glycine receptors]" Not me, unfortunately.”

Source: Cell Press

Related stories:

Antidepressants need new nerve cells to be effective
Researchers at UT Southwestern Medical Center have discovered in mice that the brain must create new nerve cells for either exercise or antidepressants to reduce depression-like behavior. In addition, the researchers found that antidepressants and exercise use the same biochemical pathway to exert their effects.
Neurons created from skin cells of elderly ALS patients
Less than 27 months after announcing that he had institutional permission to attempt the creation of patient and disease-specific stem cell lines, Harvard Stem Cell Institute (HSCI) Principal Faculty member Kevin Eggan today proclaimed the effort a success - though politically imposed restrictions and scientific advances prompted him to use a different technique than originally planned.
New Membrane Model May Unlock Secrets of Early-Stage Alzheimer's
Researchers at the National Institute of Standards and Technology and three collaborating institutions are using a new laboratory model of the membrane surrounding neurons in the brain to study how a protein long suspected of a role in early-stage Alzheimer’s disease actually impairs a neuron’s structure and function. The team’s findings are reported in a new paper in the Biophysical Journal.
Scientists demonstrate means of reducing Alzheimer's-like plaques in fly brain
Neuroscientists at Cold Spring Harbor Laboratory (CSHL) are part of a collaboration that has succeeded in demonstrating that overexpression of an enzyme in the brain can reduce telltale deposits causally linked with Alzheimer's disease.
'Cross fire' from the brain makes patients tremble
A typical symptom of Parkinson's disease is tremor in patients. A group of scientists, including Professor Peter Tass from Forschungszentrum Jülich have succeeded in demonstrating the mechanisms which cause the so-called tremor: neuron clusters in the depths of the brain drive the tremor. This discovery supports Tass' research activities aiming at developing a therapy for Parkinson's disease. A new deep brain pacemaker is to bring cells out of the diseased mode for good.
Location, location, location
Neuroscientists at Georgetown University Medical Center have solved a mystery that lies at the heart of human learning, and they say the solution may help explain some forms of mental retardation as well as provide clues to overall brain functioning.
Reprogramming Adult Stem Cells in the Brain
In recent years, stem cell researchers have become very adept at manipulating the fate of adult stem cells cultured in the lab. Now, researchers at the Salk Institute for Biological Studies achieved the same feat with adult neural stem cells still in place in the brain. They successfully coaxed mouse brain stem cells bound to join the neuronal network to differentiate into support cells instead.
Lou Gehrig's protein found throughout brain, suggesting effects beyond motor neurons
Two years ago researchers at the University of Pennsylvania School of Medicine discovered that misfolded proteins called TDP-43 accumulated in the motor areas of the brains of patients with amyotropic lateral sclerosis (ALS), or Lou Gehrig's disease. Now, the same group has shown that TDP-43 accumulates throughout the brain, suggesting ALS has broader neurological effects than previously appreciated and treatments need to take into account more than motor neuron areas. Their article appeared in last month's issue of the Archives of Neurology.

News discussion:

Medicine & Health news